News
-
2024.06.10
OTHER
New Facility for Clinical Cell Manufacturing Named
"Yanai Facility for my iPS Cell Therapy" -
2024.03.19
RESEARCHES
Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing
- 2024.02.22 RESEARCHES Registration of iPS cell stock (QHJI strain) for clinical use as a U.S. Drug Master File
- 2024.01.18 RESEARCHES CiRA_F and CIRM Sign Agreement for Widespread Use of iPS Cell Stock
- 2023.12.26 RESEARCHES Start of Investigator-Initiated Clinical Study of iPS Cell-Derived Dopaminergic Progenitor Cells for Parkinson's Disease in the United States
-
2023.06.14
RESEARCHES
Provision of HLA Genome-edited iPS Cell Stock for Clinical Use
-
2023.04.11
RESEARCHES
CiRA Foundation Signed Letter of Intent with Transformative Cell Processing Company
-
2023.04.05
RESEARCHES
Provision of a New iPS Cell Line for Clinical Use
- 2023.03.02 RESEARCHES Knowledge Palette and CiRA Foundation Executed a Collaborative Research Contract to Evaluate and Improve Quality of iPS Cells
- 2022.12.27 RESEARCHES Toshiba and the CiRA Foundation Begin Joint Research on Methods for Manufacturing iPS Cells Using Liposome technology